Lucid Diligence Brief: Novartis Rhapsido (remibrutinib) goes “beyond CSU”
Lucid Diligence Brief: Novartis Rhapsido (remibrutinib) goes “beyond CSU”…
Hematology Today—February 2, 2026
This weekly update in Hematology covers regulatory actions, late-stage clinical…
Neuroscience Weekly News - October 8th 2025
🧠 This Week in Neuroscience: China’s Nerivio Nod, Ocrevus in Pediatric MS,…
ECTRIMS 2025 Preview: Key Multiple Sclerosis Highlights to Watch
ECTRIMS 2025 at a glance Ahead of ECTRIMS 2025 in Barcelona, see what to…
Hematology Weekly News - August 4th 2025
🔬🧬 Hematology Updates: Sanofi’s Myeloma Win, AI in Lymphoma, SCD Breakthrough…